South Africa misses out on affordable generic medication because of its lax patent laws. This is the view of Julia Hill from the medical humanitarian organisation Doctors Without Borders (MSF)...A new patent law is currently being drafted in South Africa and MSF urges government to follow India’s lead by preventing pharmaceutical companies from trying to extend patents on life-saving drugs, accept when a truly new drug is invented. India manufactures large amounts of generic medicines and antiretrovirals, and the country’s law states a patent on medication is only granted when the drug has a new molecule. It’s not granted if the medication in question is merely a new formula for an existing drug...

Read article HERE